Submitted:
31 May 2025
Posted:
02 June 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
3. Results
Glaucoma vs. Healthy Eyes
Comparison of AO Rtx1™ Arteriolar Parameters Between Glaucoma and Healthy Eyes
Correlation Analysis of Supratemporal Retinal Arteriole Parameters in POAG Group
| AO−rtx1™ Parameters | Control Group | Glaucoma Group | p-Value * |
|---|---|---|---|
| TDm S (m ± SD) (µm) | 124.1 ± 12.4 | 111.0 ± 10.4 | <0.001† |
| LDm S (m ± SD) (µm) | 100.6 ± 11.1 | 85.5 ± 10.4 | <0.001† |
| 1WTm S (m ± SD) (µm) | 12.2 ± 1.3 | 12.8 ± 1.4 | 0.030 |
| 2WTm S (m ± SD) (µm) | 11.6 ± 1.2 | 12.6 ± 1.2 | <0.001† |
| WLRm S (m ± SD) | 0.238 ± 0.002 | 0.301 ± 0.04 | <0.001 |
| WCSAm S (m ± SD) (µm2) | 4197.3 ± 657.9 | 3909.5 ± 531.6 | 0.019† |
| TDm I (m ± SD) (µm) | 124.4 ± 12.0 | 114.4 ± 11.0 | <0.001† |
| LDm I (m ± SD) (µm) | 100.4 ± 10.9 | 87.7 ± 10.8 | <0.001† |
| 1WTm I (m ± SD) (µm) | 12.1 ± 1.3 | 13.4 ± 1.8 | <0.001 |
| 2WTm I (m ± SD) (µm) | 11.9 ± 1.1 | 13.3 ± 1.74 | <0.001 |
| WLRm I (m ± SD) | 0.241 ± 0.021 | 0.308 ± 0.047 | <0.001 |
| WCSAm I (m ± SD) (µm2) | 4245.6 ± 690.9 | 4257.5 ± 812.1 | 0.937 |
| AO−rtx1™ Parameters | Group A | Group B | Group C | p-Value † |
|---|---|---|---|---|
| total number of eyes | 16 | 24 | 17 | |
| TDm S (m ± SD) (µm) | 113.1 ± 11.8 | 111.6 ± 10.2 | 109.4 ± 8.7 | 0.384 |
| LDm S (m ± SD) (µm) | 87.8 ± 11.3 | 85.8 ± 10.2 | 84.0 ± 9.5 | 0.416 |
| 1WTm S (m ± SD) (µm) | 12.9 ± 1.7 | 12.9 ± 1.3 | 12.5 ± 1.1 | 0.225 |
| 2WTm S (m ± SD) (µm) | 12.5 ± 1.4 | 12.7 ± 1.2 | 12.5 ± 1.2 | 0.867 |
| WLRm S (m ± SD) | 0.293 ± 0.043 | 0.304 ± 0.048 | 0.301 ± 0.041 | 0.744 |
| WCSAm S (m ± SD) (µm2) | 3982.5 ± 657.3 | 3971.2 ± 500.3 | 3808.0 ± 394.2 | 0.539 |
| TDm I (m ± SD) (µm) | 113.2 ± 10.6 | 116.1 ± 12.2 | 112.7 ± 14.0 | 0.595 |
| LDm I (m ± SD) (µm) | 87.7 ± 9.5 | 89.3 ± 11.3 | 85.8 ± 12.2 | 0.558 |
| 1WTm I (m ± SD) (µm) | 13.0 ± 1.6 | 13.4 ± 2.2 | 13.6 ± 1.5 | 0.506 |
| 2WTm I (m ± SD) (µm) | 13.0 ± 1.8 | 13.5 ± 1.8 | 13.2 ± 1.6 | 0.503 |
| WLRm I (m ± SD) | 0.302 ± 0.042 | 0.306 ± 0.057 | 0.316 ± 0.040 | 0.656 |
| WCSAm I (m ± SD) (µm2) | 4114.3 ± 746.1 | 4349.1 ± 838.6 | 4218.9 ± 910.7 | 0.584 |
Comparison of OCTA Parameters Between Glaucoma and Healthy Eyes
Comparison of OCTA Parameters Between Glaucoma Groups
Correlations of the OCTA Results with Other Analysed Parameters
Assessment of the Correlation of the RPCP
4. Discussion
AO rtx1™
OCTA: SCP, DCP, RPCP, FAZ
SCP Correlations with OCT and VF, AO rtx1™
RPCP Correlations with BP, OCT, VF, AO rtx1™
5. Limitations
6. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology, 2081. [CrossRef] [PubMed]
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA, 1901. [CrossRef]
- Martucci, A.; Nucci, C.; Pinazo-Duran, M.D. Editorial: New perspectives in glaucoma pathophysiology, diagnosis, and treatment. Front. Med. 2023, 10, 1200427. [Google Scholar] [CrossRef] [PubMed]
- Shalaby WS, Ahmed OM, Waisbourd M, Katz LJ. A review of potential novel glaucoma therapeutic options independent of intraocular pressure. Surv Ophthalmol, 1062. [CrossRef] [PubMed]
- Flammer, J. The vascular concept of glaucoma. Surv Ophthalmol. S: (Suppl 3). [CrossRef]
- Szewczuk A, Wawrzyniak ZM, Szaflik JP, Zaleska-Żmijewska A. Is Primary Open-Angle Glaucoma a Vascular Disease? Assessment of the Relationship between Retinal Arteriolar Morphology and Glaucoma Severity Using Adaptive Optics. J Clin Med. 4: 15;13(2). [CrossRef] [PubMed] [PubMed Central]
- Flammer J, Orgül S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. [CrossRef]
- Deokule S, Vizzeri G, Boehm A, Bowd C, Weinreb RN. Association of visual field severity and parapapillary retinal blood flow in open-angle glaucoma. J Glaucoma. [CrossRef]
- Kuang TM, Zhang C, Zangwill LM, Weinreb RN, Medeiros FA. Estimating lead time gained by optical coherence tomography in detecting glaucoma before the development of visual field defects. Ophthalmology, 2002. [CrossRef]
- Chang RT, Singh K. Glaucoma suspect: diagnosis suspect: diagnosis and management. J Ophthalmol. [CrossRef]
- Ikram MK, Ong YT, Cheung CY, Wong TY. Retinal vascular calibre measurements: clinical significance, current knowledge and future perspectives. Ophthalmologica. [CrossRef] [PubMed]
- Akyol E, Hagag AM, Sivaprasad S, et al. Adaptive optics: principles and applications in ophthalmology. Eye. [CrossRef]
- Szewczuk A, Zaleska-Żmijewska A, Dziedziak J, Szaflik JP. Clinical Application of Adaptive Optics Imaging in Diagnosis, Management, and Monitoring of Ophthalmological Diseases: A Narrative Review. Med Sci Monit, e: 4;29, 9419. [CrossRef] [PubMed] [PubMed Central]
- Rao HL, Pradhan ZS, Suh MH, Moghimi S, Mansouri K, Weinreb RN. Optical coherence tomography angiography in glaucoma. J Glaucoma. [CrossRef]
- Van Melkebeke L, Barbosa-Breda J, Huygens M, Stalmans I. Optical coherence tomography angiography in glaucoma: a review. Ophthalmic Res. [CrossRef]
- Kashani AH, Chen CL, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, Shi Y, Wang RK. Optical coherence tomography angiography: A comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 6: 60. [CrossRef] [PubMed] [PubMed Central]
- Liu L, Jia Y, Takusagawa HL, Pechauer AD, Edmunds B, Lombardi L, Davis E, Morrison JC, Huang D. Optical Coherence Tomography Angiography of the Peripapillary Retina in Glaucoma. JAMA Ophthalmol, 2: [PubMed, 1045.
- Chen CL, Zhang A, Bojikian KD, Wen JC, Zhang Q, Xin C, Mudumbai RC, Johnstone MA, Chen PP, Wang RK. Peripapillary Retinal Nerve Fiber Layer Vascular Microcirculation in Glaucoma Using Optical Coherence Tomography-Based Microangiography. Invest Ophthalmol Vis Sci, 2: 57(9): Oct47 5–485. [PubMed, 2744.
- Akagi T, Iida Y, Nakanishi H, Terada N, Morooka S, Yamada H, Hasegawa T, Yokota S, Yoshikawa M, Yoshimura N. Microvascular Density in Glaucomatous Eyes With Hemifield Visual Field Defects: An Optical Coherence Tomography Angiography Study. Am J Ophthalmol, 2: 249. [PubMed, 2729.
- Yarmohammadi A, Zangwill LM, Diniz-Filho A, Suh MH, Yousefi S, Saunders LJ, Belghith A, Manalastas PI, Medeiros FA, Weinreb RN. Relationship between Optical Coherence Tomography Angiography Vessel Density and Severity of Visual Field Loss in Glaucoma. Ophthalmology, 2: 123(12):2498–2508. [PubMed, 2498.
- Wang X, Jiang C, Ko T, et al. Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study. Arch Clin Exp Ophthalmol, 1557. [CrossRef]
- https://optopol.
- Hamard P, Hamard H, Dufaux J, Quesnot S. Optic nerve head blood flow using a laser Doppler velocimeter and haemorheology in primary open-angle glaucoma and normal pressure glaucoma. Br J Ophthalmol.
- Michelson G, Langhans MJ, Groh MJ. Perfusion of the juxtapapillary retina and the neuroretinal rim area in primary open angle glaucoma. J Glaucoma.
- Yarmohammadi A, Zangwill LM, Diniz-Filho A, et al. Optical coherence tomography angiography vessel density in healthy, glaucoma suspect, and glaucoma eyes. Ophthalmol Vis Sci. [CrossRef]
- Jia Y, Wei E, Wang X et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 1322.
- Jonas JB, Nguyen XN, Naumann GO. Parapapillary retinal vessel diameter in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci, 1: 30, 1599.
- Wang, S.; Xu, L.; Wang, Y.; Wang, Y.; Jonas, J.B. Retinal vessel diameter in normal and glaucomatous eyes: The Beijing eye study. Clin. Exp. Ophthalmol. 2007, 35, 800–807. [Google Scholar] [CrossRef] [PubMed]
- Jonas JB, Nguyen XN, Gusek GC, Naumann GO. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci.
- Rader, J.; Feuer, W.J.; Anderson, D.R. Peripapillary vasoconstriction in the glaucomas and the anterior ischemic optic neuropathies. Arch. Ophthalmol. 1994, 117, 72–80. [Google Scholar] [CrossRef] [PubMed]
- Zhang, Q.; Jan, C.; Guo, C.Y.; Wang, F.H.; Liang, Y.B.; Cao, K.; Zhang, Z.; Yang, D.Y.; Thomas, R.; Wang, N.L.; et al. Association of intraocular pressure-related factors and retinal vessel diameter with optic disc rim area in subjects with and without primary open angle glaucoma. Clin. Exp. Ophthalmol. 2018, 46, 389–399. [Google Scholar] [CrossRef] [PubMed]
- Hugo, J.; Chavane, F.; Beylerian, M.; Callet, M.; Denis, D.; Matonti, F. Morphologic Analysis of Peripapillary Retinal Arteriole Using Adaptive Optics in Primary Open-angle Glaucoma. Eur. J. Gastroenterol. Hepatol. 2020, 29, 271–275. [Google Scholar] [CrossRef] [PubMed]
- Meixner, E.; Michelson, G. Measurement of retinal wall-to-lumen ratio by adaptive optics retinal camera: A clinical research. Graefe’s Arch. Clin. Exp. Ophthalmol. 2015, 253, 1985–1995. [Google Scholar] [CrossRef] [PubMed]
- Shoji T, Kanno J, Weinreb RN, Yoshikawa Y, Mine I, Ishii H, Ibuki H, Shinoda K. OCT angiography measured changes in the foveal avascular zone area after glaucoma surgery. Br J Ophthalmol. [CrossRef] [PubMed] [PubMed Central]
- Tang FY, Ng DS, Lam A, et al. Determinants of quantitative optical coherence tomography angiography metrics in patients with diabetes. Sci Rep, 2575.
- Choi J, Kwon J, Shin JW, Lee J, Lee S, Kook MS. Quantitative optical coherence tomography angiography of macular vascular structure and foveal avascular zone in glaucoma. PLoS One, e: 12, 0184.
- Kwon J, Choi J, Shin JW, Lee J, Kook MS. Glaucoma diagnostic capabilities of foveal avascular zone parameters using optical coherence tomography angiography according to visual field defect location. J Glaucoma. 1120.
- Kwon J, Choi J, Shin JW, Lee J, Kook MS. An Optical Coherence Tomography Angiography Study of the Relationship Between Foveal Avascular Zone Size and Retinal Vessel Density. Invest Ophthalmol Vis Sci, 4: 1;59(10), 4143. [CrossRef] [PubMed]
- Rao HL, Pradhan ZS, Weinreb RN, et al. Regional comparisons of optical coherence tomography angiography vessel density in primary open angle glaucoma. Am J Ophthalmol, 7: 171.
- Shoji T, Zangwill LM, Akagi T, et al. Progressive macula vessel density loss in primary open-angle glaucoma: a longitudinal study. Am J Ophthalmol, 1: 182.
- Yarmohammadi A, Zangwill LM, Manalastas PIC, Fuller NJ, Diniz-Filho A, Saunders LJ, Suh MH, Hasenstab K, Weinreb RN. Peripapillary and Macular Vessel Density in Patients with Primary Open-Angle Glaucoma and Unilateral Visual Field Loss. Ophthalmology. [CrossRef] [PubMed] [PubMed Central]
- Yarmohammadi A, Zangwill LM, Diniz-Filho A, et al. Peripapillary and Macular Vessel Density in Patients with Glaucoma and Single-Hemifield Visual Field Defect. Ophthalmology. 2017. [CrossRef]
- Yospon T, Rojananuangnit K. Optical Coherence Tomography Angiography (OCTA) Differences in Vessel Perfusion Density and Flux Index of the Optic Nerve and Peri-Papillary Area in Healthy, Glaucoma Suspect and Glaucomatous Eyes. Clin Ophthalmol, 3: 12; 17, 3011. [CrossRef] [PubMed] [PubMed Central]
| Parameters | Control Group | Glaucoma Group | p-Value * |
|---|---|---|---|
| age (m ± SD) (years) | 49.5 ± 4.4 | 51.7 ± 6.4 | 0.067 |
| HA | 8.3% | 9.8% | 0.896 |
| CHD | 4.2% | 14.8% | 0.346 |
| BMI (m ± SD) (kg/m2) | 23.7 ± 2.1 | 24.4 ± 1.8 | 0.069 |
| SBP (m ± SD) (cm Hg) | 123.4 ± 11.2 | 127.5 ± 10.1 | 0.117 |
| DBP (m ± SD) (cm Hg) | 80.5 ± 9.2 | 77.7 ± 7.1 | 0.069 |
| BCVA (m ± SD) | 0.998 ± 0.014 | 0.895 ± 0.142 | <0.001 |
| IOP (m ± SD) (cm Hg) | 15.1 ± 2.5 | 13.2 ± 2.7 | <0.001† |
| AL (m ± SD) (mm) | 23.8 ± 0.8 | 24.0 ± 1.2 | 0.683 |
| OCT c/d v (m ± SD) | 0.501 ± 0.153 | 0.811 ± 0.118 | <0.001 |
| OCT RNFL (m ± SD) (µm) | 101.3 ± 7.4 | 78.8 ± 13.9 | <0.001 |
| OCT GCC (m ± SD) (µm) | 97.7 ± 4.8 | 80.74 ± 11.8 | <0.001 |
| OCT Parameters | Group A | Group B | Group C | p-Value † |
|---|---|---|---|---|
| total number of eyes | 16 | 24 | 17 | |
| RIM AREA (m ± SD) | 0.854 ± 0.304 | 0.824 ± 0.324 | 0.492† ± 0.146 (p < 0.001) |
<0.001 |
| Vertical Cup-to-disc ratio (m ± SD) | 0.556 ± 0.051 | 0.596 ± 0.021 | 0.863†± 0.806 (p < 0.001) |
<0.001 |
| RNFL average (m ± SD) (µm) | 88.6 ± 11.4 | 82.1 ± 10.7 | 65.3† ± 10.7 (p < 0.001) |
<0.001 |
| RNFL superior (m ± SD) (µm) | 88.7 ± 13.7 | 84.1 ± 14.0 | 68.3† ± 13.5 (p = 0.004) |
<0.001 |
| RNFL inferior (m ± SD) (µm) | 89.1 ± 11.2 | 80.1 ± 10.1 | 62.1† ± 9.7 (p < 0.001) |
<0.001 |
| GCC (m ± SD) (µm) | 90.0 ± 8.8 | 83.0 ± 9.4 | 68.8† ± 8.2 (p < 0.001) |
<0.001 |
| Visual Field Parameters | Group A | Group B | Group C | p-Value * |
|---|---|---|---|---|
| total number of eyes | 16 | 24 | 17 | |
| MD (m ± SD) (dB) | −0.17 ± 0.91 | −1.89 ± 1.49 | −13.55 ± 7.66 (p† < 0.001; p†† = 0.014) |
<0.001 |
| PSD (m ± SD) (dB) | 1.56 ± 0.25 | 3.55 ± 2.04 | 10.30± 3.75 (p† < 0.001) |
<0.001 |
| OCTA Parameters | Control Group | Glaucoma Group | p-Value * |
|---|---|---|---|
| SCP FAZ (mm²) | 0.295 ± 0.125 | 0.546 ± 0.299 | <0.001 |
| SCP perimeter (mm) | 2.006 ± 0.497 | 3.444 ± 1.494 | <0.001 |
| SCP circularity | 0.700 ± 0.082 | 0.555 ± 0.159 | <0.001 |
| DCP FAZ (mm²) | 0.430 ± 0.172 | 0.651 ± 0.303 | <0.001 |
| DCP perimeter (mm) | 2.394 ± 0.471 | 3.342 ± 0.896 | <0.001 |
| DCP circularity | 0.716 ± 0.072 | 0.591 ± 0.122 | <0.001 |
| SCP Total | 38.61 ± 1.31 | 36.78 ± 1.85 | <0.001 |
| SCP Super | 38.76 ± 1.17 | 36.91 ± 1.84 | <0.001 |
| SCP Infer | 38.40 ± 2.06 | 36.63 ± 2.63 | <0.001 |
| SCP Etdrs | 38.46 ± 1.41 | 36.39 ± 3.60 | <0.001 |
| DCP Total | 41.06 ± 1.21 | 40.17 ± 2.54 | 0.024 |
| DCP Super | 41.07 ± 1.21 | 40.23 ± 2.60 | 0.073 |
| DCP Infer | 41.05 ± 1.62 | 40.10 ± 2.75 | 0.025 |
| DCP Etdrs | 41.33 ± 1.38 | 40.67 ± 2.51 | 0.090 |
| RPCP Total | 39.27 ± 1.48 | 35.42 ± 4.97 | <0.001 |
| RPCP Super | 39.44 ± 1.17 | 35.59 ± 5.01 | <0.001 |
| RPCP Infer | 39.03 ± 2.24 | 35.17 ± 5.14 | <0.001 |
| OCTA Parameters | Group A | Group B | Group C | p-Value † |
|---|---|---|---|---|
| total number of eyes | 16 | 24 | 17 | |
| SCP FAZ (mm²) | 0.564 ± 0.356 | 0.449 ± 0.190 | 0.566 ± 0.289 | 0.711 |
| DCP FAZ (mm²) | 0.569 ± 0.219 | 0.588 ± 0.308 | 0.762 ± 0.344 | 0.904 |
| SCP Total | 37.9 ± 1.2 | 36.8 ± 2.2 | 36.6 ± 0.9 p††=0.011 |
0.014 |
| SCP Super | 37.7±1.4 | 36.9±2.1 | 36.7±1.4 | 0.171 |
| SCP Infer | 38.2±1.2 | 36.6±3.1 | 36.5±1.0 p††=0.004 |
0.004 |
| DCP Total | 40.7±3.2 | 39.9±3.0 | 40.5±1.0 | 0.063 |
| DCP Super | 40.6±3.3 | 40.0±3.1 | 40.3±1.3 | 0.126 |
| DCP Infer | 40.7±3.2 | 39.8±3.0 | 40.7±1.1 | 0.157 |
| RPCP Total | 37.7±0.8 | 34.3±6.6 | 34.7±4.4 p††=0.003 |
0.033 |
| RPCP Super | 37.8±1.2 | 34.2±6.7 | 34.6±4.6 p††=0.013 |
0.017 |
| RPCP Infer | 37.5±1.5 | 34.2±6.8 | 34.8±4.5 p††=0.035 |
0.041 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).